Drug-eluting balloon for instent restenosis

The Authors’ reply We thank Chen et al 1 for their feedback on our paper2 and we fully agree with most of their comments. Instent restenosis continues to be a problem even though the risk has been massively reduced by drug coating of stents.3 A significant proportion of patients had contraindications for drug-eluting stents (DES). Regarding the short-term and long-term follow-up data available for the PACCOCATH trial, we generally …

[1]  L. Wu,et al.  Drug-eluting balloon for instent restenosis , 2013, Heart.

[2]  A. Lansky,et al.  Drug eluting balloons for de novo coronary lesions – a systematic review and meta-analysis , 2013, BMC Medicine.

[3]  P. Meier,et al.  Almanac 2012: Interventional cardiology. , 2013, Archivos de cardiologia de Mexico.

[4]  A. Kastrati,et al.  Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial , 2013, The Lancet.

[5]  G. Knapp,et al.  Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials , 2013, Heart.

[6]  P. Meier,et al.  Almanac 2012: interventional cardiology: The national society journals present selected research that has driven recent advances in clinical cardiology , 2012, Heart.

[7]  M. Böhm,et al.  Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2012, JACC. Cardiovascular interventions.

[8]  Volkmar Falk,et al.  Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .

[9]  M. Böhm,et al.  Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter , 2008, Clinical Research in Cardiology.

[10]  D. Desilvey.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2007, The American journal of geriatric cardiology.

[11]  W. Wijns.  European Association of Percutaneous Cardiovascular Interventions (EAPCI). , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.